Skip to main content
. 2022 Aug 24;9:972569. doi: 10.3389/fnut.2022.972569

Figure 1.

Figure 1

Grouping of C57BL/6 mice for prevention and therapeutic models. (A) The preventive groups of control (normal mice without prevention and infection in the preventive group), Hp (mice infected with H. pylori without prevention in the preventive group), 54 (only treated with L. paracasei ZFM54), and 54+Hp (pretreatment with L. paracasei ZFM54 before H. pylori challenge). (B) The therapeutic groups of control' (normal mice without prevention and infection in the therapeutic group), Hp' (mice infected with H. pylori without treatment in the therapeutic group), Hp+54 (treatment with L. paracasei ZFM54 after H. pylori challenge), and Hp+TT (treatment with triple therapy after H. pylori challenge).